| |
| |
|
| Insider
Information: |
Edelman Joseph |
| Relationship: |
Former 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
42 |
|
| Direct
Shares |
630,171 |
|
|
Indirect Shares
|
332,164,708 |
|
|
| Direct
Value |
$1,466,262 |
|
|
|
Indirect Value
|
$2,852,575,947 |
|
|
| Total
Shares |
332,794,879 |
|
|
| Total
Value |
$2,854,042,209 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
79
|
21
|
|
Stock
price went up :
|
50
|
11
|
| Stock
price went down : |
29
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
1.7
|
1.1
|
| Percentage
Gain/Loss : |
 13.4%
|
197.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2008-06-23 |
0 |
2008-06-23 |
6,387,546 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
10% Owner |
|
0 |
2011-11-02 |
0 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
10% Owner |
2012-11-01 |
133,133 |
2012-11-29 |
2,595,293 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
|
0 |
2017-06-19 |
4,533,728 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
|
0 |
2018-10-03 |
20,724,424 |
Premium* |
|
|
VBI Vaccines Inc |
VBIV |
10% Owner |
|
0 |
2014-07-25 |
2,610,356 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
|
0 |
2024-04-05 |
9,275,851 |
Premium* |
|
|
Aravive Inc |
ARAV |
10% Owner |
|
0 |
2017-09-22 |
2,099,563 |
Premium* |
|
|
Kadmon Holdings, Llc |
KDMN |
10% Owner |
|
0 |
2019-11-18 |
14,636,334 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2017-09-29 |
0 |
2018-08-10 |
4,070,357 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
10% Owner |
2017-12-19 |
0 |
2017-12-19 |
4,889,066 |
Premium* |
|
|
Corium International, Inc. |
CORI |
10% Owner |
2018-01-16 |
0 |
2018-10-12 |
2,724,686 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
10% Owner |
2018-01-25 |
0 |
2022-10-13 |
1,939,723 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
2018-01-30 |
0 |
2024-01-11 |
6,906,646 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
10% Owner |
2018-02-13 |
0 |
2019-01-08 |
2,253,376 |
Premium* |
|
|
Motus Gi Holdings Inc |
MOTS |
10% Owner |
2018-02-16 |
0 |
2021-01-22 |
2,660,542 |
Premium* |
|
|
Quotient Ltd |
QTNTQ |
10% Owner |
2018-05-22 |
0 |
2022-10-31 |
7,945,211 |
Premium* |
|
|
Dova Pharmaceuticals, Inc. |
DOVA |
10% Owner |
2018-06-04 |
0 |
2019-11-12 |
0 |
Premium* |
|
|
Meiragtx Holdings Plc |
MGTX |
10% Owner |
2018-06-08 |
0 |
2023-05-05 |
11,281,103 |
Premium* |
|
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
10% Owner |
2018-07-20 |
0 |
2022-04-18 |
5,321,032 |
Premium* |
|
|
Agile Therapeutics Inc |
AGRX |
10% Owner |
2018-07-26 |
0 |
2021-10-13 |
21,654,485 |
Premium* |
|
|
Verrica Pharmaceuticals Inc. |
VRCA |
10% Owner |
2018-06-19 |
0 |
2023-12-29 |
7,099,182 |
Premium* |
|
|
Athenex, Inc. |
ATNX |
10% Owner |
2019-05-06 |
0 |
2020-09-14 |
13,532,467 |
Premium* |
|
|
ADMA Biologics Inc |
ADMA |
10% Owner |
2019-05-21 |
0 |
2021-09-30 |
13,262,375 |
Premium* |
|
|
Foamix Pharmaceuticals Ltd |
FOMX |
10% Owner |
|
0 |
2019-07-29 |
11,203,881 |
Premium* |
|
|
Lyra Therapeutics, Inc. |
LYRA |
Director, 10% Owner |
2020-05-05 |
0 |
2023-05-31 |
12,757,563 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
10% Owner |
2020-06-09 |
0 |
2021-08-16 |
4,935,057 |
Premium* |
|
|
Leap Therapeutics, Inc. |
LPTX |
10% Owner |
2020-06-22 |
0 |
2020-06-22 |
8,476,496 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
Director, 10% Owner |
|
0 |
2023-12-29 |
5,402,964 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2020-10-20 |
0 |
2024-02-20 |
10,794,876 |
Premium* |
|
|
Scynexis Inc |
SCYX |
10% Owner |
2021-01-20 |
0 |
2021-01-22 |
1,800,000 |
Premium* |
|
|
Landos Biopharma, Inc. |
LABP |
Director, 10% Owner |
|
0 |
2021-02-09 |
17,960,839 |
Premium* |
|
|
Astria Therapeutics, Inc |
ATXS |
Director |
|
0 |
2024-02-01 |
6,485,420 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
3,314,032 |
Premium* |
|
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2021-04-27 |
0 |
2021-10-12 |
2,487,019 |
Premium* |
|
|
Nautilus Biotechnology, Inc |
NAUT |
10% Owner |
2021-05-24 |
497,038 |
2021-12-08 |
9,111,151 |
Premium* |
|
|
Isoplexis Corp |
ISO |
10% Owner |
2021-10-12 |
0 |
2021-10-12 |
3,554,587 |
Premium* |
|
|
Lianbio |
LIAN |
Director, 10% Owner |
|
0 |
2024-02-15 |
57,575,533 |
Premium* |
|
|
Acrivon Therapeutics, Inc. |
ACRV |
10% Owner |
|
0 |
2024-04-11 |
5,360,858 |
Premium* |
|
|
Chembio Diagnostics Inc |
CEMI |
Former 10% Owner |
2023-04-04 |
0 |
2023-04-27 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
10% Owner |
|
0 |
2023-06-06 |
2,207,753 |
Premium* |
|
|
Cargo Therapeutics, Inc. |
CRGX |
Former 10% Owner |
2023-11-14 |
0 |
2023-11-14 |
333,333 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
304 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALBO |
Albireo Pharma Inc |
10% Owner |
– – • |
2020-02-03 |
4 |
B |
$21.00 |
$5,371,989 |
I/I |
255,809 |
1,960,139 |
1.5 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
10% Owner |
– – • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
I/I |
256,386 |
1,800,541 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • • |
2020-05-05 |
4 |
D |
$16.00 |
$4,149,536 |
I/I |
(259,346) |
1,288,446 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
10% Owner |
– – • |
2019-12-19 |
4 |
B |
$13.72 |
$3,635,484 |
I/I |
263,743 |
11,116,210 |
1.5 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Director |
– • • |
2022-06-29 |
4 |
B |
$2.99 |
$807,300 |
I/I |
270,000 |
3,695,916 |
2.25 |
- |
|
| ALBO |
Albireo Pharma Inc |
10% Owner |
– – • |
2018-01-25 |
4 |
B |
$33.00 |
$9,075,000 |
I/I |
275,000 |
1,595,000 |
1.5 |
- |
|
| VRCA |
Verrica Pharmaceuticals I... |
10% Owner |
– – • |
2023-12-19 |
4 |
B |
$5.36 |
$1,484,763 |
I/I |
277,008 |
6,272,914 |
1.5 |
% |
|
| AGRX |
Agile Therapeutics Inc |
Former 10% Owner |
– – – |
2018-07-26 |
4 |
S |
$0.30 |
$89,439 |
I/I |
(298,628) |
3,231,372 |
0 |
- |
|
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2017-10-03 |
4 |
B |
$37.50 |
$11,250,000 |
I/I |
300,000 |
3,970,357 |
1.5 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2021-04-08 |
4 |
B |
$16.44 |
$4,999,996 |
I/I |
304,136 |
3,963,517 |
1.5 |
% |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
– – • |
2023-10-18 |
4 |
S |
$1.74 |
$533,308 |
I/I |
(306,499) |
8,593,586 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2018-07-18 |
4/A |
B |
$21.30 |
$6,552,902 |
I/I |
307,648 |
307,648 |
1.5 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
– – • |
2024-04-03 |
4 |
B |
$4.09 |
$1,267,274 |
I/I |
309,847 |
9,097,858 |
1.5 |
% |
|
| CORI |
Corium International, Inc... |
10% Owner |
– – • |
2018-01-18 |
4 |
B |
$12.80 |
$3,968,000 |
I/I |
310,000 |
6,357,133 |
1.5 |
- |
|
| ATHA |
Athira Pharma, Inc. |
Director |
– • • |
2021-01-25 |
4 |
B |
$22.50 |
$6,999,998 |
I/I |
311,111 |
3,425,916 |
2.25 |
- |
|
| SCYX |
Scynexis Inc |
10% Owner |
– – • |
2021-01-22 |
4 |
S |
$8.16 |
$2,629,781 |
I/I |
(319,000) |
1,800,000 |
0 |
% |
|
| ATNX |
Athenex, Inc. |
10% Owner |
– – • |
2019-06-14 |
4 |
B |
$17.69 |
$5,736,690 |
I/I |
324,290 |
9,596,022 |
1.5 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
10% Owner |
– – • |
2021-01-20 |
4 |
S |
$1.80 |
$586,166 |
I/I |
(325,648) |
3,884,894 |
0 |
% |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
10% Owner |
– – • |
2019-06-27 |
4 |
B |
$12.46 |
$4,286,124 |
I/I |
327,209 |
3,453,060 |
1.5 |
- |
|
| NAUT |
Nautilus Biotechnology, I... |
Director |
– • – |
2021-06-03 |
4 |
B |
$10.05 |
$3,317,003 |
I/I |
330,050 |
489,975 |
2.1 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2018-03-05 |
4 |
B |
$13.56 |
$4,553,814 |
I/I |
335,827 |
18,424,424 |
1.5 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
10% Owner |
– – • |
2021-08-12 |
4 |
S |
$2.23 |
$755,740 |
I/I |
(338,897) |
5,435,057 |
0 |
% |
|
| CEMI |
Chembio Diagnostics Inc |
10% Owner |
– – • |
2023-04-06 |
4 |
B |
$0.44 |
$149,160 |
I/I |
339,000 |
4,425,100 |
1.5 |
% |
|
| ADMA |
ADMA Biologics Inc |
10% Owner |
– – • |
2021-08-19 |
4 |
S |
$1.24 |
$434,436 |
I/I |
(350,352) |
14,802,978 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2018-07-20 |
4 |
B |
$17.00 |
$6,800,000 |
I/I |
400,000 |
2,280,305 |
1.5 |
- |
|
304 Records found
|
|
Page 8 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
